info@marketresearchfuture.com 📞 +1 628 258 0071(US)  📞 +44 2035 002 764(UK)
Polycaprolactone Market Research Report – Forecast till 2030

Polycaprolactone Market: Information by Form (Pellets, Nanosphere, Microsphere), Production Method (Ring Opening Polymerization, Polycondensation of Carboxylic Acid), Application (Thermoplastic Polyurethane, Healthcare), Region — Forecast till 2030

ID: MRFR/CnM/6072-HCR | February 2021 | Region: Global | 140 pages

Polycaprolactone Market Speak to Analyst Request a Free Sample

Polycaprolactone Market Synopsis 


Polycaprolactone Market was valued at USD 370.42 billion 2018 and is projected to register a CAGR of over 10.00% during the review period.

Polycaprolactone is a biodegradable, semi-crystalline thermoplastic polyester, which has a melting point of about 60°C. It is easy to manufacture, manipulate, and blend and is generally used as an additive for resins to improve their processing properties as well as characteristics such as toughness, flexibility, compression set, and tear strength.


Segmentation


The polycaprolactone market has been segmented on the basis of form, production method, application, and region.


Based on form, the market has been segmented into pellets, nanosphere, and microsphere.


On the basis of production method, the market has been segmented into ring opening polymerization and polycondensation of carboxylic acid.


By application, the global market has been segmented into thermoplastic polyurethane, healthcare, and others.


Key Players


Some of the key players operating in the global polycaprolactone market are



  • Perstorp Holding AB (Sweden),

  • Daicel Corporation (Japan),

  • Shenzhen Esun Industrial Co., Ltd (China),

  • Corbion (the Netherlands),

  • BASF SE (Germany),

  • Merck KGaA (Germany),

  • Polysciences, Inc. (US),

  • Haihang Group (China),

  • Shenzhen Polymtek Biomaterial Co., Ltd (China)

  • Durect Corporation (US).


Market Overview

The growth of the global polycaprolactone market is driven by the extensive use of polycaprolactone in the manufacturing of polyurethane and thermoplastic polyurethane. This is because it exhibits good oil, fuel, and solvent resistance as well as excellent flexibility and toughness. The growing use of thermoplastic polyurethane in major end-use industries such as automotive, construction, and packaging is one of the major factors influencing the growth of the global polycaprolactone market. The growth of the global market is also driven by the growing use of polycaprolactone in the healthcare sector for applications such as drug delivery, wound care management, sutures, wound dressing tape, tissue engineering, orthopedic, and dental implants. The biodegradable nature of the product, its non-toxicity, and biocompatibility are factors increasing their use in the sector. Furthermore, it is added as a polymeric plasticizer to polyvinyl chloride to increase its flexibility. It also can be used in re-moldable plastic on account of its low softening point. 


The extensive research and development on polycaprolactone blend to reduce the cost and improve biodegradability by mixing starch and other low-cost organic fillers is expected to create lucrative opportunities for manufacturers operating in the global market.


The manufacturers are focusing on strategic growth initiatives such as joint ventures, product development, and mergers & acquisitions. For instance, in May 2018, Perstorp AB, a global leading specialty chemicals company announced to form a joint venture named ElogioAM with 3D4Makers, a high-performance 3D printing filament producer, to develop new material solutions for the additive manufacturing industry. ElogioAM will offer the world’s first fifth-generation 3D filament, Facilan, which enables applications previously unobtainable in the medical, fashion, orthotics, and advanced prototyping. The Facilan portfolio also consists of Facilan PCL 100, which is a pure polycaprolactone filament that is being used by researchers in artificial muscles, drug-loaded implants, scaffolds, and smart materials.


However, the high cost of polycaprolactone and availability of low-cost substitutes are factors expected to hamper the global market growth during the forecast period.  


Global Polycaprolactone Market 2018, by Application (%)


Polycaprolactone Market


Source: MRFR Analysis


Regional Analysis


The global polycaprolactone market has been segmented into five regions, namely Asia-Pacific, North America, Europe, Latin America, and the Middle East & Africa.


Asia-Pacific accounted for a major market share in 2018, on account of the high use of thermoplastic polyurethane in major end-use industries such as automotive, construction, and packaging. The growth of the construction sector in the region is attributed to rapid urbanization and industrialization. Furthermore, the rising disposable income has increased the sale of automobiles in the region, which is expected to propel the demand for thermoplastic polyurethane, which and consequently boost the demand for polycaprolactone. The European and North American markets are expected to witness significant growth during the forecast period on account of the high demand for surgical equipment and biodegradable products. Increasing use of the product in modeling and splinting of prototyping systems and as feedstock is expected to boost the product demand in the coming years. Moreover, the use of polyurethane and thermoplastic polyurethane in the automotive and construction industries is projected to fuel the demand for the product in these regions.


Segmentation


The global polycaprolactone market has been segmented on the basis of form, production method, application, and region.


Based on form, the global market has been segmented into pellets, nanosphere, and microsphere.


On the basis of production method, the global market has been segmented into ring opening polymerization and polycondensation of carboxylic acid.


By application, the global market has been segmented into thermoplastic polyurethane, healthcare, and others.


Recent Development

February 2021- Osteopore, a 3D printed implant developer, has announced a collaboration with Maastricht University Medical Centre (UMC+) to design and develop a bioresorbable bone implant, which will prevent lower leg amputations. The bone implant is built with the use of 3D printing. The 3D-printed ‘cage’ is designed to support patients in reproducing new bone cells, and the first successful implication is done in a patient from the Netherlands.
Build to prevent exclusions in patients with severe lower leg fractures, 3D printed cage was constructed with the company’s proprietary 3D printing and materials technology. The structure is modified, referring to a CT scan of the patient’s lower leg. It is printed in a recyclable material to ultimately break down into carbon dioxide and water within the body. The custom-made cage is then shaped by a 3D printer depending on the patient’s CT scan.

The material to be questioned is an FDA-approved polymer known as polycaprolactone (PCL) that possesses mechanical strength identical to that of trabecular bone, a porous bone found at the ends of long bones or femur. PCL also possesses slow-degrading and malleable properties, making it an ideal choice for the material to be used in 3D printed bone implants.


Intended Audience



  • Polycaprolactone Manufacturers

  • Traders and Distributors of Polycaprolactone

  • Research and Development Institutes

  • Potential Investors

  • Raw Material Suppliers

  • Nationalized Laboratories



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: USD 370.42 Billion
  CAGR   CAGR 10.00% (2022-2030)
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2019 & 2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Basis of form, production method, application, and region.
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Perstorp Holding AB (Sweden), Daicel Corporation (Japan), Shenzhen Esun Industrial Co., Ltd (China), Corbion (the Netherlands), BASF SE (Germany), Merck KGaA (Germany), Polysciences, Inc. (US), Haihang Group (China), Shenzhen Polymtek Biomaterial Co., Ltd (China), and Durect Corporation (US).
  Key Market Opportunities   Low-cost organic fillers is expected to create lucrative opportunities.
  Key Market Drivers   Growing use of polycaprolactone in the healthcare sector


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Polycaprolactone market had valued at USD 370.42 BN in 2018.

Global Polycaprolactone market is estimated to register 10% CAGR during the forecast period (2018-2023).

By form, the pellets segment and by applications, the thermoplastic polyurethane segment holds the leading share in the global Polycaprolactone market.

Asia Pacific holds the largest share in the global Polycaprolactone market, followed by North America and Europe, respectively.

Daicel Corporation (Japan), Perstorp Holding AB (Sweden), Shenzhen Esun Industrial Co., Ltd (China), BASF SE (Germany), Corbion (the Netherlands), Merck KGaA (Germany), Haihang Group (China), Polysciences, Inc. (US), Durect Corporation (US), and Shenzhen Polymtek Biomaterial Co., Ltd (China), are some of the major players operating in the Polycaprolactone market.